October 15, 2015 / 10:15 AM / 2 years ago

Transition Therapeutics says Alzheimer's drug effective in sub-group

Oct 15 (Reuters) - Dug developer Transition Therapeutics Inc said detailed data analysis of a study of its experimental drug showed it would benefit a group of Alzheimer’s patients.

The company said on Thursday its drug was significantly effective in treating patients with severe agitation and aggression. (Reporting by Vidya L Nathan in Bengaluru; Editing by Don Sebastian)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below